GlassScriptPhysician profile
Elizabeth A Ater
NPI 1801373709
$444.12
in general payments reported to CMS, 2019-2025
16 companies · $29.46 in 2025
The $29.46 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6.99 · 2022: $150 · 2023: $185 · 2024: $72.99 · 2025: $29.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $61.03 | 2022-2024 | Korlym |
| Abbvie INC. | $59.49 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.46 | 2023 | Spiriva Respimat, Stiolto Respimat, Synjardy |
| Lilly USA, LLC | $42.53 | 2022-2023 | Mounjaro |
| Xeris Pharmaceuticals, INC. | $36.26 | 2022-2023 | Gvoke Hypopen |
| Janssen Pharmaceuticals, INC | $29.58 | 2023-2024 | Xarelto |
| Exact Sciences Corporation | $29.46 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $28.76 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.60 | 2022 | |
| Amarin Pharma, INC. | $16.41 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.11 | 2022 | |
| Amgen INC. | $14.34 | 2023 | Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.33 | 2023 | Xifaxan |
| Merck Sharp & Dohme LLC | $12.93 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $12.84 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $6.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Ater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.